Plus Therapeutics, Inc.
PSTV
$0.26
$0.00-1.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.39M | -20.58M | -19.03M | -27.12M | -12.98M |
| Total Depreciation and Amortization | 445.00K | 648.00K | 770.00K | 863.00K | 872.00K |
| Total Amortization of Deferred Charges | -- | -20.00K | -20.00K | -16.00K | 0.00 |
| Total Other Non-Cash Items | 7.21M | 6.53M | 5.14M | 10.67M | -1.67M |
| Change in Net Operating Assets | -6.04M | -2.31M | -3.72M | 3.39M | 3.22M |
| Cash from Operations | -20.78M | -15.73M | -16.86M | -12.21M | -10.55M |
| Capital Expenditure | -67.00K | -48.00K | -35.00K | -109.00K | -146.00K |
| Sale of Property, Plant, and Equipment | 30.00K | 30.00K | 30.00K | 30.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -817.00K | 305.00K | -1.01M | -110.00K | -3.97M |
| Cash from Investing | -854.00K | 287.00K | -1.02M | -189.00K | -4.11M |
| Total Debt Issued | 4.49M | 3.74M | 3.74M | 7.03M | 3.29M |
| Total Debt Repaid | -7.00M | -7.00M | -7.00M | -10.59M | -4.00M |
| Issuance of Common Stock | 38.54M | 35.54M | 18.68M | 22.97M | 7.31M |
| Repurchase of Common Stock | -- | 0.00 | -45.00K | -45.00K | -419.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.72M | -4.77M | -175.00K | 0.00 | 0.00 |
| Cash from Financing | 30.31M | 27.51M | 15.20M | 19.37M | 6.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.68M | 12.07M | -2.68M | 6.97M | -8.48M |